Craft

STAAR Surgical

Stock Price

$30.3

2024-10-29

Market Capitalization

$1.5 B

2024-10-29

Revenue

$239.4 M

FY, 2025

STAAR Surgical Summary

Company Summary

Overview
STAAR Surgical is a company that designs, develops, manufactures, and markets lenses. It offers implantable contact, surgical, and foldable intraocular lenses for refractive, cataract, and glaucoma surgery.
Type
Public
Status
Active
Founded
1982
HQ
Lake Forest, CA, US | view all locations
Website
http://staar.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Patrick F. Williams

    Patrick F. Williams, Chief Financial Officer

  • Scott D. Barnes

    Scott D. Barnes, Chief Medical Officer

  • Keith Holliday

    Keith Holliday, Chief Technology Officer

  • William Goodmen

    William Goodmen, Vice President, Global Human Resources

Operating MetricsView all

Trademarks

11
37.5%

FY, 2023

Countries Covered

75

FY, 2023

LocationsView all

5 locations detected

  • Lake Forest, CA HQ

    United States

    25651 Atlantic Ocean Drive

  • Hamburg, HH

    Germany

    Harksheider Str. 3

  • Singapore

    Singapore

    229 Mountbatten Road, #02-41 Mountbatten Square

  • Bern, BE

    Switzerland

    Hauptstrasse 104

  • Oldham, England

    United Kingdom

    Earl Business Centre Ste. 30, Earl Mill

STAAR Surgical Financials

Summary Financials

Revenue (Q1, 2026)
$93.5M
Gross profit (Q1, 2026)
$68.9M
Net income (Q1, 2026)
$5.2M
Cash (Q1, 2026)
$131.9M
EBIT (Q1, 2026)
$8.0M
Enterprise value
$1.4B

Footer menu